Atrophy in the mucosa neighboring an intestinal-type gastric adenocarcinoma by comparing the Sydney vs. OLGA systems
Main Article Content
Keywords
Stomach neoplasms, Gastrectomy, Adenocarcinoma, Atrophy
Abstract
Background: Gastric carcinoma causes about 700 000 deaths worldwide per year. Is feasible detect it in earlier stages. The aim of this article is to assess the atrophy in the mucosa neighboring an intestinal-type gastric adenocarcinoma by comparing the Sydney vs. OLGA systems.
Methods: Twenty-eight individuals with intestinal-type gastric adenocarcinoma (Lauren) were compared with 32 non-neoplastic cases. Both groups had undergone total gastrectomy. Two pathologists made a consensus-based assessment of the atrophy in non-neoplastic corpus and antral epithelium using the Sydney and OLGA Systems. The mean, median, and distribution of the frequencies were obtained using the measuring and distribution scales of the study variables. The sensitivity, specificity, and predictive values, both positive and negative, for gastric cancer were calculated through the dichotomy of advanced atrophy-positive and advanced atrophy-negative scales.
Results: Twenty-four of the 28 cases with intestinal-type gastric carcinoma showed an advanced atrophy with the OLGA system, with a sensitivity and specificity of 77 and 85 %, respectively. Conversely, 4 of the 28 individuals showed an advanced atrophy with the Sydney system, with a sensitivity and specificity of 14 and 100 %, respectively.
Conclusions: The OLGA system has a high sensitivity and specificity (77 y 85 % respectively) for the recognition of preneoplastic changes in the mucosa neighboring a gastric carcinoma.
References
Pisani P, Parkin DM, Bray F, Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 1999; 83(1):18-29.
Allum WH, Powell DJ, McConkey CC, Fielding JW. Gastric cancer: a 25 year review. Br J Surg 1989; 76 (6):535-540.
Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epid Biomarkers Prev 2009; 18(7):1945-1952.
Secretaría de Salud. Subsecretaría de prevención y promoción de la salud. Compendio de Cáncer 2002 Registro histopatológico de neoplasias malignas en la República Mexicana (CD ROM). Dirección general de epidemiología México. 2002.
Correa P, Haenszel W, Cuello C, Tannembaum S, Archer M. A model for gastric cancer epidemiology. Lancet 1975; 2(7924): 58-60.
Correa P. A human model of gastric carcinogenesis. Cancer Res1988; 48(13):3554-3360.
Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis 2012; 13(1): 2-9.
Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J Gastroenterol 2005; 11(6):791-796.
Ho SB. Premalignant lesions of the stomach. Semin Gastrointest Dis 1996; 7(2): 61-73.
Komoto K, Haruma K, Kamada T, Tanaka S, Yoshikara M, Sumii K, et. al. Helicobacter pylori infection and gastric neoplasia: Correlations with histological gastritis and tumor histology. Am J Gastroenterol 1998; 93(8):1271-1276.
Uemura N, Okamoto S, Yamamoto S. Helicobacter pylori infection and the development of gastric cancer. N Eng J Med 2001; 345(11):784-789.
Villako K, Kekki M, Maaroos HI, Sipponen P, Uibo R, Tammur R, et. al. Chronic gastritis: progression of inflammation and atrophy in a six year endoscopic follow-up of a random sample of 142 Estonian urban subjects. Scand J Gastroenterol 1991; 186: 135-141.
Hackelrsberger A, Günther T, Schultze V, Peitz U, Malfertheiner P. Role of aging in the expression of helicobacter pylori gastritis in the antrum, corpus and cardia. Scand J Gastroenterol 1999; 34(2):138-143.
Sipponen P, Keikki M, Siurala M. Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer 1983; 52(6):1062-1068.
Sipponen P, Keikki M, Haapakoski J, Ihamäki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985; 35: 173-177.
Sipponen P, Seppala K, Aärynen M, Helske T, Kettunen P. Chronic gastritis and gastroduodenal ulcer, a case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis. Gut 1989; 30(7):922-929.
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20(10):1161–1181.
Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Path 2005; 36(3): 228-233.
Rugge M, Correa P, Dixon MF, Fiocca R, Hattori T, Lechago J, et. al . Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002; 16 (7):1249-1259.
Rugge M, Genta RM; OLGA Group. Staging gastritis: an international proposal. Gastroenterology 2005; 129(5):1807-1808.
Lauren P. The two histological main types of gastric carcinoma. Diffuse and so called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
Rugge M, Meggio A, Penneli G, Piscioli F, Giaconelli L, De Prettis G, et. al. Gastritis staging in clinical practice; the OLGA staging system. Gut 2007; 56 (5):631-636.
Rugge M, Boni M, Pennelli G, de Bona M, Giacoenelli L, Fasson M, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinic-pathologic follow up study. Alimen Pharmacol Ther 2010; 31:1104-1111
Rugge M, Correa P, Di Mario F, El Omar E, Fiocca R, Geboes K, et.al. OLGA staging for gastritis; a tutorial. Dig and Liver Dis 2008; 40(8): 650-658.
Rugge M, Correa P, Dixon MF, Hattori T, Leandro G, Lewin K, et. al. Gastric dysplasia: The Padova international classification. Am J Surg Pathol 2000; 24(2):167-176.
Genta R. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996, 20 (Suppl 1): S23-30.
Annibale B, Lahner E. Assessing the severity of atrophic gastritis. Eur J Gastroenterol Hepatol 2007; 19(12): 1059-1063.
Genta RM. Helicobacter pylori, inflammation, mucosal damage, and apoptosis, pathogenesis and definition of gastric atrophy. Gastroenterology 1997; 113(6 Suppl): S51-55.
Arista-Nasr J, Jiménez-Rosas F, Uribe-Uribe N, Herrera-Goepfert R, Lazos-Ochoa M. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas. Am J Gastroenterol 2001; 96(6):1746-1750.
Satoh K, Osawa H, Yoshizawa M, Nakano H, Hirosawa T, Kihira K, et.al. Assessment of atrophic gastritis using the OLGA system. Helicobacter 2008; 13 (3):225-229.
de Vries AC, van Grieken NC, Looman CW, Casparie MK, de Vries E, Meijer JA, et.al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134(4): 945-952.
Capelle LG, de Vries AC, Haringsma J, Ter Borg F, de Vries RA, Bruno MJ, et. al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointestinal Endoscopy 2010; 71(7):1150-1158.
Rugge M, Fassan M, Pizzi M, Farinati F, Sturniolo GC, Plebani M, et. al. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J Gastroenterology 2011; 17 (41):4596-4661.
Ramírez Mendoza P, González Angulo J, Ángeles Garay U, Segovia-Cuevas GA. Evaluación de la atrofia gástrica: Comparación entre los sistemas Sidney and OLGA. Rev Med Inst Mex Seguro Social 2008; 46(2):135-139.
Gutierrez-Gonzalez L, Wright NA. Biology of intestinal metaplasia in 2008; more than a simple phenotypic alteration. Dig Liver Dis 2008; 40(7):510-522.
Silva E, Teixeira A, David L, Carneiro F, Reis CA, Sobrinho-Simoes SJ, et. al. Mucin as key molecules for the classification of intestinal metaplasia of the stomach. Virchows Arch 2002; 440(3):311-317.
Leung WK, Lin SR, Ching JY, To KF, Ng EK, Chang FK, et. al. Factors predicting progression of gastric intestinal metaplasia: results of a randomized trial on Helicobacter pylori eradication. Gut 2004; 53(9): 1244-1249.
Abraham SC, Montgomery EA, Sing VK, Yardley JH, Wu TT. Gastric adenomas: intestinal type and gastric type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol 2002; 26(10):1276-1285.
Park do Y, Srisvastava A, Kim GH, Mino -Kenudson M, Desphande V, Zukerberg LR, et. al. Adenomatous and foveolar gastric dysplasia: distinct patterns of mucin expression and background intestinal metaplasia. Am J Surg Pathol. 2008; 32(4): 524-533.
Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003; 56(1): 1-9.
Ji BT, Chow WH, Yang G, Mc Laughlin JK, Gao RN, Zheng W, et. al. The influence of cigarrette smoking, alcohol, and green tea consumption of the risk of carcinoma of the cardia and distal stomach in Shanghai, China. Cancer 1996; 77(12): 2449-2457.